Pharmaceutical Companies Request Recusal of FTC Chair from Insulin Case

They claim she and other commissioners are prejudiced against pharmaceutical companies. This week, the top three pharmaceutical companies in the United States requested that Lina Khan, chair of…

Read More

HHS Issues Final Guidance for Medicare Prescription Payment Plan

New initiative to ease out-of-pocket drug costs and cap annual expenses at $2,000 for Medicare beneficiaries by 2025. The Department of Health and Human Services (HHS), through the…

Read More

Legislation Introduced to Cap Insulin Prices 

Representative Bush says, “We cannot solely rely on the whims of pharmaceutical companies.“ Senator Bernie Sanders of Vermont has introduced a bill that would cap the list price…

Read More

Legislation to Reduce Insulin Costs Proposed in Senate

Bipartisan bill could impact 8.4 million Americans.  On Wednesday, Senator Jeanne Shaheen of New Hampshire and Senator Susan Collins of Maine unveiled a draft for bipartisan legislation to…

Read More

Administration Unveils $35 Insulin Copay Plan

Part of pledge to fight high drug prices On Wednesday, the Trump Administration through the Center for Medicare and Medicaid Services pledged once again to fight high drug…

Read More

Back to top
FE3